####################
# Output from PRIME (v2.0)
# Alleles: C0401
# Affinity predictions: MixMHCpred (/Users/annieborch/Documents/programs/MixMHCpred-master/MixMHCpred)
# Input file: /Users/annieborch/Documents/IMPROVE/IMPROVE_git/IMPROVE_tool/results/predictions/PRIME/tempPept.txt
#
# PRIME is freely available for academic users.
# Private companies should contact Nadette Bulgin (nbulgin@lcr.org) at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
# To cite PRIME2.0, please refer to:
# Gfeller et al. Predictions of immunogenicity reveal potent SARS-Cov-2 CD8 T-cell epitopes, BioRxiv (2022).
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_C0401	Score_C0401	%RankBinding_C0401
VFMRPFHEV	0.516	0.068569	0.530	C0401	0.516	0.068569	0.530
YFPQKFPLTF	0.829	0.049045	0.451	C0401	0.829	0.049045	0.451
IFMDRGMIV	0.318	0.093241	0.426	C0401	0.318	0.093241	0.426
YLNLDDTVF	0.199	0.118866	0.312	C0401	0.199	0.118866	0.312
LWDEVVARV	0.002	0.305074	0.001	C0401	0.002	0.305074	0.001
